Ziphius Therapeutics addresses urgent global public health needs by creating mRNA-based vaccines, providing a more robust immune response than traditional vaccines.

Ziphius_Vaccines 1.jpeg

Image by Louis Reed

About Us

Ziphius Vaccines is a global biopharmaceutical company dedicated to develop next-generation vaccines for the prevention of infectious diseases. Our mission is to reduce the impact of infectious diseases on global health care.

The Team

Our team is composed of highly dedicated experts, with strong scientific and pharmaceutical backgrounds and a set of complementary skills.

Chris Cardon

Chief Executive Officer

Tom Almey

Chief Operating Officer

Mathieu Ghadanfar

Business Development Officer

Chief Medical Officer

Lara van Opdorp

Medical Liaison Manager

Scott Lippens

Executive Assistant

Kristof Vercruysse

Chief Scientific Officer

David Schwicker

Strategic Advisor

Maxine Vangampelaere

Medical Writer

Simon Sergeant

Medical Writer

Séan Mc Cafferty

Senior Researcher

Ashiqul Haque (PhD)

Senior Researcher

Itishri Sahu (PhD)

Senior Researcher

Sophie Valembois

Organic Chemist

Ben Verschueren

Animal Caretaker

Alexandra Danneels

Pharmaceutical Development Manager

Sophie Naessens

R&D Scientist